Quadrant Capital Group LLC lessened its position in shares of Colgate-Palmolive (NYSE:CL – Get Rating) by 27.6% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 2,013 shares of the company’s stock after selling 769 shares during the period. Quadrant Capital Group LLC’s holdings in Colgate-Palmolive were worth $152,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in CL. Centaurus Financial Inc. raised its stake in shares of Colgate-Palmolive by 9.3% during the 4th quarter. Centaurus Financial Inc. now owns 4,199 shares of the company’s stock worth $358,000 after buying an additional 357 shares during the last quarter. FDx Advisors Inc. raised its stake in Colgate-Palmolive by 93.8% in the 4th quarter. FDx Advisors Inc. now owns 12,160 shares of the company’s stock valued at $1,038,000 after purchasing an additional 5,886 shares during the last quarter. AGF Investments Inc. acquired a new position in Colgate-Palmolive in the 4th quarter valued at about $249,000. Fifth Third Bancorp raised its stake in Colgate-Palmolive by 1.0% in the 4th quarter. Fifth Third Bancorp now owns 120,100 shares of the company’s stock valued at $10,249,000 after purchasing an additional 1,144 shares during the last quarter. Finally, RFG Advisory LLC raised its stake in Colgate-Palmolive by 12.3% in the 4th quarter. RFG Advisory LLC now owns 5,343 shares of the company’s stock valued at $456,000 after purchasing an additional 586 shares during the last quarter. Institutional investors and hedge funds own 78.12% of the company’s stock.
Insider Activity at Colgate-Palmolive
In related news, VP Philip G. Shotts sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, May 16th. The stock was sold at an average price of $78.52, for a total transaction of $785,200.00. Following the sale, the vice president now directly owns 46,094 shares of the company’s stock, valued at approximately $3,619,300.88. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Colgate-Palmolive news, insider John W. Kooyman sold 19,683 shares of the stock in a transaction on Monday, May 16th. The stock was sold at an average price of $78.49, for a total value of $1,544,918.67. Following the sale, the insider now directly owns 7,007 shares of the company’s stock, valued at $549,979.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Philip G. Shotts sold 10,000 shares of the stock in a transaction on Monday, May 16th. The stock was sold at an average price of $78.52, for a total value of $785,200.00. Following the completion of the sale, the vice president now directly owns 46,094 shares in the company, valued at $3,619,300.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 79,683 shares of company stock valued at $6,297,119. Corporate insiders own 0.32% of the company’s stock.
Colgate-Palmolive Stock Down 0.6 %
Colgate-Palmolive (NYSE:CL – Get Rating) last announced its earnings results on Friday, July 29th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Colgate-Palmolive had a return on equity of 315.10% and a net margin of 10.98%. The company had revenue of $4.48 billion for the quarter, compared to analyst estimates of $4.35 billion. During the same period in the prior year, the company posted $0.80 EPS. Colgate-Palmolive’s quarterly revenue was up 5.3% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive will post 3.03 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Shareholders of record on Thursday, July 21st will be given a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.34%. The ex-dividend date of this dividend is Wednesday, July 20th. Colgate-Palmolive’s payout ratio is 81.39%.
Wall Street Analysts Forecast Growth
CL has been the subject of several analyst reports. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Tuesday. Atlantic Securities downgraded shares of Colgate-Palmolive from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $92.00 to $80.00 in a research note on Tuesday, May 3rd. Barclays upped their price objective on shares of Colgate-Palmolive from $71.00 to $74.00 and gave the company an “equal weight” rating in a research note on Tuesday. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Colgate-Palmolive from $88.00 to $87.00 in a research note on Tuesday, July 19th. Finally, UBS Group upped their price objective on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company a “buy” rating in a research note on Monday, August 1st. Twelve research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $84.57.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.